Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma
- Author(s)
- Falchi, L; Hutchings, M; Carlo-Stella, C; Morschhauser, F; Dickinson, M; Cartron, G; Khan, C; Tani, M; Martinez-Lopez, J; Bartlett, NL; Salar, A; Brody, JD; Leppä, S; Berthier, A; Kallemeijn, M; Relf, J; Tchaleu, FB; Lundberg, L; Bachy, E;
- Details
- Publication Year 2025-04-01,Volume 110,Issue #4,Page 999-1004
- Journal Title
- Haematologica
- Publication Type
- Research article
- Publisher
- Ferrata-Storti Foundation
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.3324/haematol.2024.286257
- Open Access at Publisher's Site
https://doi.org/10.3324/haematol.2024.286257- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-12-12 03:22:30
Last Modified: 2025-05-08 07:28:35